Institute for Anatomy, University of Veterinary Medicine Hannover, Foundation, Bischofsholer Damm 15, 30173, Hannover, Germany.
Small Animal Clinic, University of Veterinary Medicine Hannover, Foundation, Bünteweg 9, 30559, Hannover, Germany.
Theriogenology. 2020 May;148:122-131. doi: 10.1016/j.theriogenology.2020.03.001. Epub 2020 Mar 5.
The blood-testis barrier (BTB) consists of different cell-to-cell connections, including tight junction proteins like claudin-11 (CLDN11). For dogs, only limited data is published dealing with these proteins in general. Therefore, their physiological relevance, their postnatal expression, and their distribution pattern in pathological conditions, e.g. in altered spermatogenesis and testicular neoplasia were assessed. Canine testes from routine castrations, and those sent in for diagnostic purposes were investigated. Based on morphological evaluation, the dogs and testes were divided into groups: (1) dogs with normal spermatogenesis, (2) four months old prepubertal dogs, (3) intratubular seminoma, (4) diffuse seminoma, (5) Sertoli cell tumours (SCT), (6) Leydig cell tumours (LCT), and (7) dogs with impaired spermatogenesis (e.g. mixed atrophy). In order to examine possible alterations of the BTB components, immunohistochemistry (IHC) and immunofluorescence using a commercial antibody against CLDN11 was performed. Sertoli cell (SC) nuclei (SOX9) and peritubular myoid cells (smooth-muscle-actin, SMA) were also assessed using IHC. Additionally, semi-quantitative Western-blot (WB) and RT-PCR analyses of CLDN11 were conducted. In tubules with normal spermatogenesis, IHC of CLDN11 revealed a basolateral staining at BTB localisation. In prepubertal cords, CLDN11 was diffusely expressed along the cytoplasmic extensions of SCs supposing that the BTB was neither built up nor functional, yet. A shift from weakly expressed CLDN11 between/in residual SCs in intratubular seminoma to only small CLDN11 immunopositive stained spots in the cytoplasm of remaining SOX9-positive SCs in diffuse seminoma was detectable. Reduction or even loss of CLDN11 expression in diffuse seminoma was confirmed using RT-PCR and WB analyses, thus indicating that in seminoma, CLDN11 was downregulated at transcriptional level and completely lost its sealing function. Basal SCs in SCT still showed a CLDN11/SOX9 co-localisation, suggesting that luminal neoplastic SCs undergo de-differentiation during tumour progression. In LCT, no CLDN11 was detectable. Dogs with mixed atrophy showed an upregulation of CLDN11 in tubules with spermatogenic arrest on mRNA and protein level, leading to the conclusion that within these tubules regulatory mechanisms lost their equilibrium. For the first time, the spatial expression of CLDN11 in prepubertal canine testis, impaired spermatogenesis, intratubular seminoma and its absence in diffuse seminoma and LCT was shown. Since altered CLDN11 levels could be part of adaptive mechanisms to modify BTB integrity, further functional investigations to characterize the canine BTB need to be conducted.
血睾屏障由不同的细胞间连接组成,包括紧密连接蛋白,如 Claudin-11 (CLDN11)。对于狗来说,只有有限的数据发表了关于这些蛋白质的一般信息。因此,评估了它们在生理上的相关性、出生后的表达以及在病理条件下的分布模式,例如在改变的精子发生和睾丸肿瘤中。研究了来自常规去势的犬睾丸和因诊断目的而送检的睾丸。根据形态学评估,将犬和睾丸分为以下几组:(1) 精子发生正常的犬,(2) 四个月大的未成熟犬,(3) 管内精原细胞瘤,(4) 弥漫性精原细胞瘤,(5) Sertoli 细胞瘤 (SCT),(6) Leydig 细胞瘤 (LCT),和 (7) 精子发生受损的犬 (例如混合萎缩)。为了检查血睾屏障成分可能发生的改变,进行了免疫组织化学 (IHC) 和使用针对 CLDN11 的商业抗体的免疫荧光检测。还使用 IHC 评估了 Sertoli 细胞 (SC) 核 (SOX9) 和管周肌样细胞 (平滑肌肌动蛋白,SMA)。此外,还进行了 CLDN11 的半定量 Western blot (WB) 和 RT-PCR 分析。在精子发生正常的小管中,CLDN11 的 IHC 显示出在 BTB 定位处的基底外侧染色。在未成熟的索中,CLDN11 沿着 SC 的细胞质延伸弥漫表达,这表明 BTB 尚未建立或不起作用。在管内精原细胞瘤中,从较弱表达的 CLDN11 之间/在残留的 SC 之间到弥漫性精原细胞瘤中剩余的 SOX9 阳性 SC 细胞质中仅可见少量 CLDN11 免疫阳性染色点,可以检测到 CLDN11 的转移。通过 RT-PCR 和 WB 分析证实了弥漫性精原细胞瘤中 CLDN11 的表达减少甚至丢失,这表明在精原细胞瘤中,CLDN11 在转录水平下调,完全失去了其密封功能。SCT 中的基底 SC 仍显示 CLDN11/SOX9 共定位,表明肿瘤进展过程中管腔内的肿瘤性 SC 经历去分化。在 LCT 中,未检测到 CLDN11。在 mRNA 和蛋白质水平上,具有精子发生阻滞的小管中,混合萎缩的犬显示 CLDN11 的上调,这导致结论是,在这些小管中,调节机制失去了平衡。首次显示了 Claudin-11 在未成熟犬睾丸、精子发生受损、管内精原细胞瘤中的空间表达,以及在弥漫性精原细胞瘤和 LCT 中缺失。由于改变的 CLDN11 水平可能是改变 BTB 完整性的适应性机制的一部分,因此需要进行进一步的功能研究来表征犬的 BTB。